173 related articles for article (PubMed ID: 37739041)
1. Safety of surfactant excipients in oral drug formulations.
Maher S; Geoghegan C; Brayden DJ
Adv Drug Deliv Rev; 2023 Nov; 202():115086. PubMed ID: 37739041
[TBL] [Abstract][Full Text] [Related]
2. Formulation strategies to improve the efficacy of intestinal permeation enhancers
Maher S; Brayden DJ
Adv Drug Deliv Rev; 2021 Oct; 177():113925. PubMed ID: 34418495
[TBL] [Abstract][Full Text] [Related]
3. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.
Zhang W; Li Y; Zou P; Wu M; Zhang Z; Zhang T
AAPS J; 2016 Jul; 18(4):830-43. PubMed ID: 27184579
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
[TBL] [Abstract][Full Text] [Related]
6. Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells.
Anderberg EK; Nyström C; Artursson P
J Pharm Sci; 1992 Sep; 81(9):879-87. PubMed ID: 1432633
[TBL] [Abstract][Full Text] [Related]
7. The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs.
Dahlgren D; Roos C; Johansson P; Tannergren C; Lundqvist A; Langguth P; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Aug; 547(1-2):158-168. PubMed ID: 29758344
[TBL] [Abstract][Full Text] [Related]
8. The impact of common pharmaceutical excipients on the gut microbiota.
Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
[TBL] [Abstract][Full Text] [Related]
9. The effects of excipients on transporter mediated absorption.
Goole J; Lindley DJ; Roth W; Carl SM; Amighi K; Kauffmann JM; Knipp GT
Int J Pharm; 2010 Jun; 393(1-2):17-31. PubMed ID: 20417699
[TBL] [Abstract][Full Text] [Related]
10. Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations.
Dahlgren D; Sjöblom M; Lennernäs H
Eur J Pharm Biopharm; 2019 Sep; 142():411-420. PubMed ID: 31306749
[TBL] [Abstract][Full Text] [Related]
11. The gut in the beaker: Missing the surfactants?
Wilson CG; Halbert GW; Mains J
Int J Pharm; 2016 Nov; 514(1):73-80. PubMed ID: 27863685
[TBL] [Abstract][Full Text] [Related]
12. Ensuring Product Stability - Choosing the Right Excipients.
Veronica N; Heng PWS; Liew CV
J Pharm Sci; 2022 Aug; 111(8):2158-2171. PubMed ID: 35526577
[TBL] [Abstract][Full Text] [Related]
13. Exposure to a Nonionic Surfactant Induces a Response Akin to Heat-Shock Apoptosis in Intestinal Epithelial Cells: Implications for Excipients Safety.
Cavanagh RJ; Smith PA; Stolnik S
Mol Pharm; 2019 Feb; 16(2):618-631. PubMed ID: 30608696
[TBL] [Abstract][Full Text] [Related]
14. Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRP.
Zou L; Pottel J; Khuri N; Ngo HX; Ni Z; Tsakalozou E; Warren MS; Huang Y; Shoichet BK; Giacomini KM
Mol Pharm; 2020 Mar; 17(3):748-756. PubMed ID: 31990564
[TBL] [Abstract][Full Text] [Related]
15. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
[TBL] [Abstract][Full Text] [Related]
16. Natural surfactant-based topical vehicles for two model drugs: Influence of different lipophilic excipients on in vitro/in vivo skin performance.
Savić S; Weber C; Savić MM; Müller-Goymann C
Int J Pharm; 2009 Nov; 381(2):220-30. PubMed ID: 19616085
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review on pharmaceutical excipients.
Pockle RD; Masareddy RS; Patil AS; Patil PD
Ther Deliv; 2023 Jul; 14(7):443-458. PubMed ID: 37464784
[TBL] [Abstract][Full Text] [Related]
18. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
[TBL] [Abstract][Full Text] [Related]
19. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems.
Sadhukha T; Layek B; Prabha S
Drug Deliv Transl Res; 2018 Apr; 8(2):375-386. PubMed ID: 28462499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
